Evidence indicates that dysfunctions in the insulin signaling pathway cause IR, which is pivotal in the pathogenesis, development, and progression of NAFLD/MAFLD disease [35]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.